<DOC>
	<DOCNO>NCT01489696</DOCNO>
	<brief_summary>The study aim compare blood pressure pulse male healthy subject take mirabegron tamsulosin alone combination .</brief_summary>
	<brief_title>A Study Evaluate Cardiovascular Interactions Between Mirabegron Tamsulosin</brief_title>
	<detailed_description>Treatment arm 1 ( effect mirabegron tamsulosin ) : Subjects randomize one two sequence . Subjects receive 2 single dos tamsulosin , absence mirabegron presence mirabegron . 24-hour Cardiovascular ( CV ) profile take baseline day single dose tamsulosin /combination dose sequence . Regular blood sample also take check potential Pharmacokinetic ( PK ) interaction . Treatment arm 2 ( effect tamsulosin mirabegron ) : Subjects randomize one two sequence . Subjects receive 2 single dose mirabegron , absence tamsulosin presence tamsulosin . 24-hour CV profile take baseline day single dose mirabegron/combination dose sequence . Regular blood sample also take check potential PK interaction .</detailed_description>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Body Mass Index equal 18.5 less 30.0 kg/m2 Known suspect hypersensitivity mirabegron and/or tamsulosin HCl , component formulation use Any liver function test ( i.e . Alanine Aminotransferase ( ALT ) Asparate Aminotransferase ( AST ) upper limit normal repeat measure ( least one time ) Any clinically significant history asthma , eczema , allergic condition previous severe hypersensitivity drug ( exclude nonactive hay fever ) Any prior clinically significant psychiatric history include hospitalization mental health management Subject risk urinary retention base medical history Any clinically significant abnormality follow investigator 's review prestudy physical examination , Electrocardiogram ( ECG ) clinical laboratory test Heart rate and/or blood pressure measurement screen admission visit follow : Heart rate &lt; 50 &gt; 90 bpm ; mean systolic blood pressure &lt; 90 mm Hg &gt; 140 mmHg ( &gt; 160 mmHg subject 65 year old ) ; mean diastolic blood pressure &lt; 60 mm Hg &gt; 90 mmHg ( &gt; 100 mmHg subject 65 year old ) ( blood pressure measurement take subject rest supine position 5 min ; heart rate measure automatically ; take triplicate ) A QTc interval &gt; 430 m repeat measurement ( least two time ) , history syncope , orthostatic hypotension , vertigo , cardiac arrest , unexplained cardiac arrhythmia torsades de pointes , structural heart disease , family history Long QT Syndrome ( LQTS ) A hemoglobin value &lt; 12.5 g/dl ( 7.8 mmol/l ) and/or hematocrit value &lt; 37.9 % and/or Red Blood Cell count &lt; 4.08 T/l ( 4080 mm3 )</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Mirabegron</keyword>
	<keyword>Tamsulosin</keyword>
	<keyword>Phase 1</keyword>
</DOC>